Blood-based biomarkers in the anti-amyloid era of Alzheimer’s disease: clinical utility, implementation challenges, and future directions
- DOI
- 10.1080/17582024.2026.2734618
- Published
- 2026-09-26
- Container
- Neurodegenerative Disease Management
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1080/17582024.2026.2734618,
title = {Blood-based biomarkers in the anti-amyloid era of Alzheimer’s disease: clinical utility, implementation challenges, and future directions},
author = {Bo-Lin Ho and Yuan-Han Yang},
year = {2026},
journal = {Neurodegenerative Disease Management},
doi = {10.1080/17582024.2026.2734618},
url = {https://doi.org/10.1080/17582024.2026.2734618}
}RIS
TY - JOUR TI - Blood-based biomarkers in the anti-amyloid era of Alzheimer’s disease: clinical utility, implementation challenges, and future directions AU - Bo-Lin Ho AU - Yuan-Han Yang PY - 2026 JO - Neurodegenerative Disease Management DO - 10.1080/17582024.2026.2734618 UR - https://doi.org/10.1080/17582024.2026.2734618 ER -
APA
Ho, B., & Yang, Y. (2026). Blood-based biomarkers in the anti-amyloid era of Alzheimer’s disease: clinical utility, implementation challenges, and future directions. Neurodegenerative Disease Management. https://doi.org/10.1080/17582024.2026.2734618
Source records
- crossref · retrieved 2026-09-27T07:34:26.276Z